Antimalarial drugs currently in development.
作者信息
Gutteridge W E
机构信息
Wellcome Research Laboratories, Beckenham, Kent.
出版信息
J R Soc Med. 1989;82 Suppl 17(Suppl 17):63-6; discussion 66-8.
Abstract
摘要
相似文献
1
Antimalarial drugs currently in development.目前正在研发的抗疟药物。
J R Soc Med. 1989;82 Suppl 17(Suppl 17):63-6; discussion 66-8.
2
New antimalarial drugs.新型抗疟药物。
Angew Chem Int Ed Engl. 2003 Nov 10;42(43):5274-93. doi: 10.1002/anie.200200569.
3
4
Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.阿托伐醌与其他抗疟药物在体外对恶性疟原虫的相互作用。
Exp Parasitol. 1995 May;80(3):373-81. doi: 10.1006/expr.1995.1049.
5
Antimalarial drug resistance and combination chemotherapy.抗疟药耐药性与联合化疗
Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):739-49. doi: 10.1098/rstb.1999.0426.
6
Mode of action and mechanisms of resistance for antimalarial drugs.抗疟药物的作用方式和耐药机制。
Pharmacol Ther. 2001 Feb;89(2):207-19. doi: 10.1016/s0163-7258(00)00115-7.
7
Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based antimalarials.基于青蒿素的抗疟药物在化学、药物化学及药物设计方面的当前进展。
Curr Pharm Des. 1999 Feb;5(2):101-38.
8
Drug use and design in the nineties.
Acta Leiden. 1991;60(1):147-56.
9
Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.青蒿素类抗疟药作用机制的思考：第1部分——“碳自由基”和“血红素”假说
Infect Disord Drug Targets. 2013 Aug;13(4):217-77. doi: 10.2174/1871526513666131129155708.
10
[Malaria: a medical and economic problem].[疟疾：一个医学和经济问题]
Presse Med. 2006 Apr;35(4 Pt 1):555-7. doi: 10.1016/s0755-4982(06)74637-1.
引用本文的文献
1
Tafenoquine and G6PD: a primer for clinicians.泰法诺喹与 G6PD：临床医生指南。
J Travel Med. 2019 Jun 1;26(4). doi: 10.1093/jtm/taz023.
2
Approval of Tafenoquine for Malaria Chemoprophylaxis.特非那喹用于疟疾化学预防的批准。
Am J Trop Med Hyg. 2019 Jun;100(6):1301-1304. doi: 10.4269/ajtmh.19-0001.
3
Tafenoquine for travelers' malaria: evidence, rationale and recommendations. travellers’ malaria: evidence, rationale and recommendations.
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay110.
4
Parameters determining the relative efficacy of hydroxy-naphthoquinone inhibitors of the cytochrome bc1 complex.决定细胞色素bc1复合物的羟基萘醌抑制剂相对效力的参数。
Biochim Biophys Acta. 2007 Apr;1767(4):319-26. doi: 10.1016/j.bbabio.2007.02.014. Epub 2007 Feb 27.
5
Artemisia annua L.: a source of novel antimalarial drugs.青蒿：新型抗疟药物的来源。
Pharm Weekbl Sci. 1990 Oct 19;12(5):169-81. doi: 10.1007/BF01980041.
6
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.羟基萘醌566C80对刚地弓形虫速殖子和组织包囊具有显著的体外和体内活性。
Antimicrob Agents Chemother. 1991 Feb;35(2):293-9. doi: 10.1128/AAC.35.2.293.
本文引用的文献
1
Introduction of halofantrine for malaria treatment.卤泛群用于疟疾治疗的介绍。
Parasitol Today. 1988 Sep;4(9):238-9. doi: 10.1016/0169-4758(88)90136-6.
2
Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.维拉帕米逆转恶性疟原虫对氯喹的耐药性。
Science. 1987 Feb 20;235(4791):899-901. doi: 10.1126/science.3544220.
3
New anti-protozoal agents.新型抗寄生虫药。
Int J Parasitol. 1987 Feb;17(1):121-9. doi: 10.1016/0020-7519(87)90033-6.
4
Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro.谷胱甘肽还原酶抑制剂作为潜在的抗疟药物。亚硝基脲对恶性疟原虫的体外作用。
Biochem Pharmacol. 1988 Mar 1;37(5):855-60. doi: 10.1016/0006-2952(88)90172-4.
5
In vitro and in vivo studies of the effects of halogenated histidine analogs on Plasmodium falciparum.卤化组氨酸类似物对恶性疟原虫影响的体外和体内研究。
Antimicrob Agents Chemother. 1988 Nov;32(11):1655-9. doi: 10.1128/AAC.32.11.1655.
6
In vitro activity of natural and synthetic naphthoquinones against erythrocytic stages of Plasmodium falciparum.天然和合成萘醌对恶性疟原虫红细胞内期的体外活性。
Braz J Med Biol Res. 1988;21(3):485-7.
7
8
Prophylactic treatment of vivax and falciparum malaria with low-dose doxycycline.小剂量强力霉素对间日疟和恶性疟的预防性治疗
J Infect Dis. 1988 Nov;158(5):1124-7. doi: 10.1093/infdis/158.5.1124.
9
The in vitro and in vivo antimalarial activity of some Mannich bases derived from 4-[7'-bromo (and chloro)-1',5'-naphthyridin-4'-ylamino]phenol and 4-(7'-trifluoromethylquinolin-4'-ylamino)phenol.一些源自4-[7'-溴（和氯）-1',5'-萘啶-4'-基氨基]苯酚和4-(7'-三氟甲基喹啉-4'-基氨基)苯酚的曼尼希碱的体外和体内抗疟活性。
Ann Trop Med Parasitol. 1988 Apr;82(2):127-34. doi: 10.1080/00034983.1988.11812219.
10
The antimalarial activity of Spathodea campanulata stem bark extract on Plasmodium berghei berghei in mice.火焰树茎皮提取物对小鼠伯氏疟原虫的抗疟活性。
Planta Med. 1988 Apr;54(2):122-5. doi: 10.1055/s-2006-962367.
Zotero 插件